Show/hide main menu

News

News Highlights

46th Maudsley Debate: the law's drug problem

Posted on 28/11/2012
MaudsleyDrugs-flipped

On November 15th 2012, King’s College London’s Institute of Psychiatry collaborated with the Institute of Ideas for the first time to create a Maudsley Debate on the challenges associated with legal highs, novel psychoactive substances and less mainstream drugs. 

The police, parliamentarians, addictions psychiatrists, general practitioners, the voluntary sector and family members of those harmed by these drugs were represented. 

The podcast of the debate is now available on the Maudsley Debate Podcast page

A radical departure from the house style meant that there were five speakers, no polarised speeches and no vote. Despite the absence of a democratic voice the audience took part in a lively debate. 

In the preceding weeks, the ban of more synthetic cannabinoids and methoxetamine were announced, along with increased detection of deaths from mephedrone and the appearance of 57 new drugs within 11 months. 

Did the panel and audience find solutions to this fast changing situation? Listen for yourself, the constructive discourse fleshed out some promising ideas involving education, novel treatment services and adaptation of regulatory mechanisms. 

One thing was clear from all present. The continuation of the status quo cannot cope with the growing challenges of what one young journalism student in the audience dubbed a 'drug revolution'. 

Speakers:

Dr Owen Bowden-Jones, Consultant Psychiatrist and Chair, Faculty of Addictions, Royal College of Psychiatrists 

Dr Michael Fitzpatrick, GP; Author, The Tyranny of Health: doctors and the regulation of lifestyle and Defeating Autism: a damaging delusion 

Tim Hollis, Chief Constable, Humberside Police; Chair, ACPO Drugs Committee 

Molly Meacher, Chair, All Party Parliamentary Group on Drug Policy Reform; Former Chair, East London NHS Foundation Trust 

Chair: David Bowden, Coordinator, UK Battle Satellites; Poetry Editor, Culture Wars; TV Columnist, Spiked 

To find out more about the debate, please click here.

Rss Feed Atom Feed

News Highlights:

News Highlights...RSS FeedAtom Feed

Research may explain why some people with schizophrenia do not respond to treatment

Research may explain why some people with schizophrenia do not respond to treatment

Description
Research from King's Institute of Psychiatry suggests that the molecular mechanism leading to schizophrenia may be different in patients who fail to respond to anti-psychotic medication compared to patients who do respond.
Pregnant women with mental health disorders need more help to quit smoking

Pregnant women with mental health disorders need more help to quit smoking

Description
Pregnant women with mental health disorders are facing too many barriers to help them quit smoking during pregnancy despite their willingness to accept support, finds a new study led by King's Institute of Psychiatry.
Discovery of molecular pathway of Alzheimer's disease reveals new drug targets

Discovery of molecular pathway of Alzheimer's disease reveals new drug targets

Description
Scientists at King's Institute of Psychiatry have discovered the molecular pathway that drives the changes seen in the brains of Alzheimer's patients, revealing new targets for drug discovery that could be exploited to combat the disease.

Share this story:

 

Follow Us

@kingscollegelon

Live Twitter feed...

@kingscollegelon
Join the conversation
Sitemap Site help Terms and conditions Privacy policy Accessibility Modern slavery statement Contact us

© 2017 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454